Navigation Links
Genomic Health Announces First Quarter 2011 Financial Results and Business Progress
Date:5/3/2011

enues

352

963Total revenues

49,810

41,229OPERATING EXPENSES:Cost of product revenues

9,059

8,966Research and development

10,091

7,793Selling and marketing

20,536

18,016General and administrative

10,356

8,327Total operating expenses

50,042

43,102Loss from operations

(232)

(1,873)Interest and other income

65

108Interest and other expense

50

21Loss before income taxes

(217)

(1,786)Income tax provision

69

146Net loss

$
(286)

$ (1,932)Basic and diluted net loss per share

$   (0.01)

$   (0.07)Shares used to compute basic and diluted net loss per share

29,104

28,636Genomic Health, Inc.Condensed Consolidated Balance Sheets(in thousands)As ofMarch 31,

December 31, 2011

2010(Unaudited)Cash and cash equivalents

$   18,157

$
31,183Short-term investments

45,435

45,635Accounts receivable, net

16,262

14,306Prepaid expenses and other current assets

7,307

6,541Total current assets

87,161

97,665Long-term investments

12,982

-Property and equipment, net

10,685

10,345Restricted cash

110

608Long-term equity investments

2,770

500Other assets

1,706

1,743Total assets

$ 115,414

$
,861Accounts payable

$
4,737

$
3,968Accrued expenses and other current liabilities

14,821

16,305Deferred revenues

2,466

2,821Other liabilities

1,537

1,657Stockholders’ equity

91,853

86,110Total liabilities and stockholders’ equity

$ 115,414

$
,861The condensed consolidated balance sheet at December 31, 2010 has been derived from the audited consolidated financial statements at that date included in the Company's
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Transgenomic, Inc. Presentations to Describe High-Sensitivity Detection of Cancer Biomarkers at the 2011 American Association for Cancer Research Meeting
2. Transgenomic Announces Discovery of a Novel Technique Which Enhances Analytic Sensitivity of Standard Sanger Sequencing to 1%
3. Genomic Health Presents Multiple International Studies Demonstrating Worldwide Value of Oncotype DX® Breast Cancer Test
4. Reminder Webcast Alert: Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
5. Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
6. Everist Genomics Laboratory Receives Approval From U.S. Regulatory Authorities For High Complexity Clinical Testing
7. Researchers use genomics to investigate TB outbreak
8. Transgenomic to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on February 17
9. Genomic Health Announces Results from Biomarker Discovery Program Utilizing Next-Generation Sequencing to Compare Normal and Tumor Breast Tissue
10. Sigma Life Science Collaborates with Cofactor Genomics to Develop Publically Available Rat Genome Database
11. Four Community Hospitals Join DNA Directs Genomic Medicine Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... November 21, 2014 During his lifetime ... the need to surround himself with great people and ... entrepreneur, his friends often marveled at his extraordinarily courageous ... his life and -- even with his death impending—that’s ... Alzheimer’s disease that would ultimately take his life. , ...
(Date:11/22/2014)... The “Chiral Chromatography Columns Market by type (Empty, ... by Application [GC, LC (HPLC, UHPLC, Flash Chromatography, ... and studies the major market drivers, restraints, opportunities, ... Rest of the World. , Browse 90 market ... pages and in-depth TOC on “Chiral Chromatography Columns ...
(Date:11/21/2014)... , Nov. 21, 2014   TRU-D SmartUVC LLC ... feature their superbug-killing UVC automated disinfection robot, TRU-D SmartUVC, at ... week from Nov. 23 to 26 at Stand 23. ... the United Kingdom,s largest infection-related event ... prevention societies to one of the leading events of its ...
(Date:11/21/2014)... The report, "Synthetic Biology Market ... kits), Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning ... - Global Forecast to 2018", analyses and ... and challenges. , Browse 99 market data ... pages and in-depth TOC of the global ...
Breaking Biology Technology:Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 2TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 2Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 4
... Oclaro, Inc. (NASDAQ: OCLR ), a tier-one ... that its 9xx nm high-power laser diode bars have ... epidermal medical applications, for use in its next generation ... laser platform represents a new era in biomedical applications ...
... WASHINGTON, May 17, 2011 New data presented ... of moderate to severe chronic prostatitis/chronic pelvic pain ... annual meeting of the American Urological Association, RAPAFLO(R) ... quality of life. Chronic prostatitis/chronic pelvic ...
... P f enex Inc.,s Reagent Proteins division ... (BMF) to the United States Food and Drug Administration for ... of conjugate vaccine products by its partners. ... to multiple partners in support of their novel conjugate vaccine ...
Cached Biology Technology:Pantec Biosolutions Selects Oclaro Laser Diode Bars for Transdermal Drug Delivery and Tissue Ablation Systems 2Pantec Biosolutions Selects Oclaro Laser Diode Bars for Transdermal Drug Delivery and Tissue Ablation Systems 3Pantec Biosolutions Selects Oclaro Laser Diode Bars for Transdermal Drug Delivery and Tissue Ablation Systems 4Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 2Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 3Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 4Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 5Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 6Pfenex Inc., Through Its Reagent Proteins Business Division, Announces Submission of Biologics Master File for Recombinant CRM197 to US FDA 2Pfenex Inc., Through Its Reagent Proteins Business Division, Announces Submission of Biologics Master File for Recombinant CRM197 to US FDA 3
(Date:11/21/2014)... 20, 2014   Atmel® Corporation (NASDAQ: ... and touch technology solutions, today launched the industry,s first ... the widest V cc range from 1.7V to ... faster I 2 C bus communication speeds, and are ... making them ideal for consumer, industrial, computer, and medical ...
(Date:11/15/2014)... NEW YORK , Nov. 13, 2014  While we ... of technology Doctor McCoy used in "Star Trek" to gain ... and tools designed to work with smartphones and tablets for ... corners of the healthcare world. This may seem a tad ... are ready to adopt some of these technological opportunities into ...
(Date:11/7/2014)... conjunction with the Glendale and ... the Verdugos has announced the " GLENDALE - ... to keep the Verdugo Regional Crime Lab operational after its ... existence, the Lab has processed more than 400 DNA samples, ... "Because our number one priority is the wellbeing of ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2
... Elephant seals are helping scientists overcome a critical blind-spot ... circulation and sea ice production and its influence on ... a team of French, Australian, US and British scientists ... Sciences, elephant seals fitted with special oceanographic sensors ...
... combination of chemotherapy agents that have been tested in ... to standard treatment for advanced non-small cell lung cancer, ... of Clinical Cancer Research, a journal of ... phase II multicenter study of 56 patients with an ...
... -- There,s little debate that, when a tree falls near ... are more difficult to answer: Who is affected by the ... And who is responsible for deciding how to replace the ... professor and doctoral student, and presented at two international conferences, ...
Cached Biology News:Southern Ocean seals dive deep for climate data 2Experimental chemotherapy regimen shows promise in treating advanced lung cancer 2If a street tree falls... what does it take to make sound policy? 2If a street tree falls... what does it take to make sound policy? 3